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Aim: In adult medicine, rates of investigation and prescribing appear to be increasing. Such 
information is lacking for paediatrics. We audited Australian paediatricians’ practices in 2013 
to determine changes since 2008 in (i) conditions seen; (ii) consultation duration; (iii) 
imaging and pathology ordered; and (iv) prescribing. 
Methods: Patient-level prospective audit of paediatricians’ secondary care practice. In 
November-December 2013, members of the Australian Paediatric Research Network were 
invited to complete standardised forms for 100 consecutive patients or all patients seen over 
two weeks, whichever was completed first. Main measures: Diagnoses, consultation duration, 
pathology and/or imaging investigations ordered, rate of medication prescription. Analyses: 
Hierarchical linear modelling clustered at the paediatrician level.  
Results: 180 paediatricians (48% of those eligible) contributed 7,102 consultations. The 
proportion of developmental/behavioural conditions rose from 48% (SD 31%) to 60% (SD 
30%) in new and 54% (SD 28%) to 66% (SD 28%) in review consultations in 2013 compared 
with 2008. More paediatricians reported diagnoses of autism spectrum disorder (39% to 56%, 
p=0.002), attention-deficit/hyperactivity disorder (47% to 55%, p=0.05), and intellectual 
disability (18% to 36%, p=0.001) in first consultations. Mean consultation duration and 
pathology/imaging ordering rates were stable. Prescribing rates increased from 39% to 45% 
of consultations for the top 10 new diagnoses, and from 57% to 68% of consultations for the 
top 10 review diagnoses. 
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Conclusions: Paediatricians are seeing more children with developmental-behavioural 
conditions, prescribing more, and demonstrating wide variation in their practice.  The latter 
suggests both over- and under-treatment.  
  




In adult medicine, delivery of many health care practices has increased in recent years. Some 
of these are clearly beneficial, reflecting either treatment advances such as combination 
therapy for HIV1 or the use of genomic testing to direct more specific cancer therapy.2  
However, other widely-implemented activities are costly, of uncertain benefit and may even 
be harmful including screening activities (eg for prostate cancer), imaging (eg for back pain) 
and prescribing (eg for mild hypertension).  
 
Like adults, today’s children live in a world where the epidemiology of health and disease 
continues to evolve, and where the choices regarding care that could be provided are greater 
than ever before. On the one hand, the incidence of some conditions has clearly risen in 
recent years (eg diabetes, food allergy), and for others new evidence from rigorous trials has 
clearly demonstrated benefits from medication (eg stimulants for core symptoms of attention 
deficit hyperactivity disorder,3 selective serotonin reuptake inhibitors for moderate/severe 
anxiety).4 In these instances, an increase in prescribing might be seen as appropriate. On the 
other hand, children’s healthcare is as open as that of adults to over-diagnosis (when a true 
abnormality is discovered, but detection of that abnormality does not benefit the patient) and 
overtreatment/overuse (when excess medication or procedures are provided to patients for 
both correct and incorrect diagnoses).5  Many problems, such as learning problems, autism 
spectrum disorders and mental health disorders, may also be open to ‘diagnosis creep’, where 
less well defined difficulties that might in earlier decades have been considered normal are 
increasingly coming to medical attention.    
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Before issues of ‘too much medicine’ or ‘too little medicine’ can be addressed in paediatric 
practice, it is necessary to know ‘how much medicine’ is occurring. Yet such evidence is 
scant. For example, while Australian national data are collected on medications dispensed 
and investigations ordered by doctors, diagnostic data are not linked to these practices. 
Therefore, it is impossible to say whether a particular practice represents optimal care. As a 
starting point, it is vital to document the evolution of current practice, specifically secular 
trends in diagnosis, investigation and management. One way of doing this is via national 
practice audits of care. Ideally, these would bring together all of the necessary information - 
diagnoses, treatments and investigations - into a single whole-of-practice framework.  
 
In Australia, general paediatricians provide care to children and adolescents, predominantly 
in secondary care settings including private practices, hospital outpatient clinics, and 
community health centres. To be seen by a general paediatrician, children must be referred by 
a general practitioner which allows families to receive a Medicare (financial) rebate for the 
consultation.6 In 2008, we conducted the first national audit of general and community 
paediatric practice. We found that developmental and behavioural conditions accounted for 
the bulk of the general paediatric casemix.7 We repeated this audit in 2013. This paper reports 
diagnoses and management practices and compares them with those reported in 2008. We 
hypothesised that, compared to 2008, paediatricians in 2013 would report: (i) an increase in 
the proportion of consultations for developmental and behavioural conditions; (ii) a decrease 
in time spent per consultation; (iii) an increase in imaging and pathology testing; and (iv) an 
increase in prescription of medications.  
 




This was a prospective clinical audit of general paediatricians’ outpatient practice in public 
hospital outpatient clinics, community health centres and private rooms.   
All members of the Australian Paediatric Research Network (APRN), a national, practice-
based, secondary care research network, were invited via email to take part in October 2013. 
Audit booklets were mailed to eligible and interested paediatricians. Paediatricians were 
asked to complete a data form for each patient seen over a two week period from November 
18th to December 2nd 2013, or for 100 consecutive patients, whichever came first. 
Paediatricians mailed completed booklets back to the research team. 
Measures 
To report change over time, the data collection form (Figure 1) replicated the 2008 form.7 
This was modelled on the form used by Bettering the Evaluation and Care of Health 
(BEACH). BEACH has for many years conducted an annual audit of a national random 
sample of Australian general practitioners.8  The form included the consultation date, start 
and end times; practice setting; family and paediatrician practice postcode, language spoken 
at home, the child’s height and weight; diagnoses made; investigations ordered; medications 
prescribed (including over the counter medications such as vitamins); vaccines administered; 
referrals made; and Medicare consultation items numbers billed encompassing simple (ie one 
condition) and complex (ie two or more conditions) new and review consultation item 
numbers.  
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A list of the 60 most common diagnostic codes, replicating the 2008 audit, was provided on 
the back of each consultation form. Paediatricians could either write the code corresponding 
to a diagnosis or write the diagnosis if it was not on the list. Each booklet comprised 100 data 
collection forms and instructions on how to complete the booklet.   
All completed booklets were hand cleaned and then scanned and verified using Cardiff 
Teleform 10.2 software by the research team. Members of the APRN steering committee 
(HH, MW, DE, MD, and GR) assigned codes and cross-checked the 56 diagnoses recorded in 
addition to the 60 most common diagnoses (ie total of 116 diagnoses coded). Paediatrician 
practice postcodes were used to calculate census derived Socio-Economic Indexes for Areas 
(SEIFA) index for relative social disadvantage (national mean of 1000, standard deviation of 
100).9 Lower scores reflect greater disadvantage.   
Ethics approval was granted by The Royal Children’s Hospital Human Research Ethics 
Committee (HREC #33197). 
Statistical analyses 
To determine nation-wide generalisability, demographic and practice characteristics of APRN 
member responders were compared with characteristics of APRN member non-responders 
and Australian general paediatricians, based on the 2013 Australian Health Practitioner 
Regulation Agency workforce survey (completed by around 96% of medical specialists). 
Characteristics of children seen were calculated as means and standard deviations (eg for age) 
and proportions (eg for gender, number of comorbidities). Consultations were categorised as 
“new” or “review” based on Medicare billing coding. 
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To compare data from 2008 and 2013, we used multi-level models (random effect 
regression),10 which allowed for analysis of all paediatricians, regardless of participation in 
both 2008 and 2013 waves. We clustered consultations at the paediatrician level (Level 2), 
allowing for repeated measurement of consultations (Level 1) within paediatrician as well as 
over time. Medication, consult and paediatrician rate within diagnosis models were clustered 
at the paediatrician level only. We examined whether there was evidence of change over time 
in any of our outcomes of interest (types of consultations, time spent per consultation, use of 
imaging and pathology investigations, prescription of medication). All analyses were 
performed using Stata version 13.1.11 
 
RESULTS  
Of the 451 APRN members, 75 (17%) were ineligible (eg on leave, illness, uncontactable, 
retired), and 180 of the remaining 376 (48%) participated. Paediatricians working in the state 
of Victoria were over represented, while those working in New South Wales, South Australia, 
Tasmania and the Northern Territory were under represented relative to the national 
distribution of paediatricians.12 Compared with general paediatricians across Australia, 
responders were more likely to be female, younger, and working part time (Table 1).  
 
Paediatricians collected data on 7102 consultations over the two week period. Children were 
seen at practices from a broad socioeconomic range (SEIFA mean 1000.4, SD 69.6). Most 
children seen were male (57%), with a mean age of 7.6 years (standard deviation 5.6 years). 
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The proportion of children diagnosed with 1, 2, and 3 or more conditions was 35.1%, 32.7% 
and 31.8%, respectively (Table 2).   
Similar to 2008, the majority of 2013 consultations were for developmental and behavioural 
problems but the proportion of consultations including such conditions increased across both 
new and review consultations from 2008 to 2013 (see Table 3). Overall, developmental and 
behavioural problems rose from 48% (SD 31%) to 60% (SD 30%) of paediatricians’ new 
consultations, and from 54% (SD 28%) to 66% (SD 28%) of review consultations (both 
p<0.001). In 2013, autism spectrum disorders were the most common new diagnosis (15% in 
2013, versus 5% in 2008) and more paediatricians reported making this diagnosis in 2013 
than in 2008 (56% versus 39%). A similar pattern was seen in review diagnoses. Attention-
deficit/hyperactivity disorder not only remained the most common condition managed by 
paediatricians overall, but increased as a diagnosis in both new and review consultations 
(from 10% to 14% and from 22% to 28%, respectively). Anxiety, sleep problems and 
intellectual disability (IQ < 70) were all more likely to be diagnosed in 2013 compared with 
2008. Consultation length changed little between 2008 and 2013 for either new or review 
consultations. 
In both 2008 and 2013 imaging was ordered in fewer than 6% of consultations, with no 
change between the two audits. Similarly, the rate of pathology orders was unchanged (new, 
14.8% in 2008 and 15% in 2013; review, 6% in both 2008 and 2013). 
The prescribing of medications including over the counter products increased over this time 
for almost all common conditions, falling slightly in only one of the top 10 new conditions 
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(language delay) and one of the top 10 review conditions (well baby check). Increases in 
prescribing rates were particularly marked for autism (28% of new diagnoses in 2008, 42% in 
2013, p=0.04), anxiety (59% to 74% for review diagnoses, p=0.008), sleep disturbance (29% 
to 52% for new diagnoses, p=0.003), behaviour (53% to 65% for review diagnoses, p=0.04), 
constipation (75% to 89% for review diagnoses, p=0.006), and asthma (75% to 86% for new 
diagnoses, p=0.007) (Table 3). There were large standard deviations in mean rates of 
prescribing across all conditions, indicating wide inter-paediatrician variation. We found a 
similar pattern of changes when we restricted our sample to the 113 paediatricians who 
competed the audit at both time points (Table 4). 
 
DISCUSSION  
In the five year period 2008-2013, consultations for developmental and behavioural problems 
rose to become an even higher proportion of Australian general / community paediatric 
practice. Unlike the stability seen in mean consultation duration and rates of imaging and 
pathology investigations, prescribing rates rose markedly across virtually every condition and 
for both new and review consultations.  
 
Strengths and limitations: This study has a number of strengths. It is the only Australian 
audit of paediatric practice in non-acute settings and used an established data collection 
method.8 It collected rich data over two time points, with the same 113 (42%) APRN 
paediatricians participating both times. We could find no comparable international audits of 
paediatric speciality care.   




Among the study’s limitations are that only around half of the eligible APRN members took 
part, and those that did were more likely to be female, younger and working part time than 
Australian general paediatricians overall. As such our results may not generalise to male or 
older paediatricians or those working full time.  However, our 2008 audit showed no 
evidence of developmental-behavioural caseload differences by paediatrician gender.7 Even 
though collected prospectively and in real time, our audit relied on reported and not actual 
practice. Use of electronic records may be considered more valid, but still relies on accurate 
input of data and is not a viable option given that only 50% of Australian paediatricians use 
electronic medical records.13 While we reported medications prescribed by the child’s first 
listed diagnosis, many children had more than one diagnosis and so the medication may have 
been for a comorbid diagnosis. Paediatricians were more likely to record seeing a child with 
three or more diagnoses in 2013 (32%) compared with 2008 (23%) and this may explain 
some of the increase in prescribing. 
 
Interpretation of findings: There are many possible reasons why a much higher proportion 
of paediatric outpatient practice now involves developmental and behavioural problems; 
some or all may co-exist, and none can be confirmed by this or other published studies. ‘Too 
much medicine’ is one possibility, and could be supported by the increasing proportion of 
children being diagnosed with less categorical conditions such as anxiety and sleep problems 
from 2008 to 2013. However, this rise could equally represent: (1) a greater availability of 
private paediatric services, (2) increased parental awareness and hence presentation to general 
practitioners (the gateway to paediatric referral), (3) the rising proportion of longer general 
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practice consultations now given over to diseases of ageing, thus squeezing out children,14 
and/or (4) changes in funding and remunerative structures. For example, the recent provision 
of Australian government funding ($AUS 12,000 per child) for early intervention services for 
certain conditions has almost certainly prompted families to attend paediatricians for a 
diagnosis; however, this funding does not apply to other conditions where diagnoses as a 
proportion of consultations have also increased. Whatever the reason, these increases could 
be “good”; for example, recent data from a Swedish population-based study indicate that 
autism diagnosis is now approaching the population prevalence of the autism phenotype.15 
On the other hand, these increases could be “bad”, if they represent over-diagnosis of 
children with milder difficulties who are less likely to benefit, and may even experience 
resulting harm.  
 
Similarly, the marked rise in prescribing could represent overtreatment and/or better 
implementation of existing treatments and availability of new ones. For example, melatonin 
has been shown in a controlled trial to improve sleep onset in children with 
neurodevelopmental disabilities,16 and its availability through compounding pharmacies has 
led to rapid uptake by Australian paediatricians.17  On the other hand, there is good evidence 
that brief (ie 2-3 sessions) non-pharmacological interventions are effective in reducing sleep 
problems including sleep onset delay in children without neurodevelopmental disorders18,19 as 
well as those with attention deficit disorder.20 The potential factors underlying the rising use 
of medication for anxiety are less clear. While non-pharmacological interventions such as 
cognitive behavioural therapy (CBT) are effective in treating anxiety21 their intensity 
(typically requiring 10 sessions or more21), cost and lack of availability may make medication 
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a practical alternative. Furthermore, children may have already received non-pharmacological 
therapy at the time of their first consultation with the paediatrician. For more severe anxiety, 
the synergistic use of CBT and medications such as sertraline is more effective than either 
therapy alone and therefore use of medication may reflect appropriate management.22 
 
Whatever the appropriateness of medication for different conditions, the marked inter-
paediatrician variation evidenced by the large standard deviations suggests that both over- 
and under-treatment are common. Large variation has also been reported in hospitalists’ 
management of common child health conditions in the USA, even for therapies with a proven 
evidence-base.23 Similarly, a review of practice variation for 16 common child conditions 
found that unwarranted variation in care, largely reflecting over-treatment, was widespread 
across conditions and health sectors.24  
 
Paediatricians are seeing more children with developmental-behavioural conditions, 
prescribing more, and demonstrating wide variation in their practice.  Whether paediatricians 
are over diagnosing and over-treating conditions requires further research to establish 
whether making these diagnoses leads to better outcomes for children and families.5 Ideally 
this would involve prospective, routine data collection of paediatricians’ diagnosis, 
investigations, and treatment, at a population level, with a marker of severity of conditions. 
Further research into systems (eg access to services), patient (eg costs and family 
preferences) and paediatrician-level (eg knowledge and training) factors driving 
paediatricians’ practices is also needed.   
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What is already known on this topic: 
• Rates of investigation and prescribing in adult medicine are known to be increasing 
however, such information is lacking for paediatrics. 
• Analysis of information on diagnoses, investigations, and treatments - available in a 
single whole-of-practice framework - is needed in order to describe trends in 
paediatric medicine.  
What this study adds: 
• In a national, prospective audit of diagnoses, investigations, and treatments, 
Australian paediatricians report diagnosing more developmental and behavioural 
conditions and prescribing more medication over a 5 year period. 
• Marked inter-paediatrician variation suggests both over- and under-treatment. 
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Table 1: Comparison of Australian general paediatricians and responding and non-





All paediatricians APRN responders APRN non-responders 
(n=1442) (n=180) (n=196) 
Male 701 (48.6) 82 (45.6) 112 (57.1) 
       Age (years) 
      <44 440 (30.5) 71 (39.4) 87 (44.4) 
45–54 463 (32.1) 60 (33.3) 65 (33.2) 
55–64 342 (23.7) 31 (17.2) 37 (18.9) 
65+ 146 (10.1) 13 (7.2) 2 (1.0) 
State 
      Australian Capital 
Territory 23 (1.6) 8 (4.4) 5 (2.6) 
New South Wales 486 (33.7) 49 (27.2) 63 (32.1) 
Northern Territory n.p. - 1 (0.6) 7 (3.6) 
Queensland 270 (18.7) 27 (15.0) 32 (16.3) 
South Australia 112 (7.8) 4 (2.2) 11 (5.6) 
Tasmania n.p. - 3 (1.7) 3 (1.5) 
Victoria 356 (24.7) 75 (41.7) 50 (25.5) 
Western Australia 133 (9.2) 12 (6.7) 25 (12.8) 
       




      Part-time 373 (25.9) 111 (61.7) 69 (35.2) 
Full-time 837 (58.0) 50 (27.8) 16 (8.2) 
       Practice location 
      Metropolitan 1182 (82.0) 128 (71.1) 145 (74.0) 
Regional/Rural 216 (15.0) 49 (27.2) 38 (19.4) 
* Missing data due to poor response for item. 
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Table 2. Patient characteristics in 2008 and 2013 
 Characteristic  2008  2013 p 
 
 
(n=8345)  (n=7102)  
 Male, n (%) 4796 (57.5)  4019 (56.6) 0.77 
 Age (years), mean (SD) 6.6 (5.5)  7.6 (5.6) <0.001 
 English first language, n (%) 7333 (87.9)  6705 (94.4) <0.001 
 SEIFA, mean (SD) 996.6 (75.8)  1004.3 (69.6) <0.001 
Diagnosis      <0.001 
    1 3841 (46.0)  2490 (35.1)  
    2 2578 (30.9)  2325 (32.7)  
    3 or more 1906 (22.8)  2255 (31.8)  
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Table 3: 2013 top 10 ranked new and review consultations, comparing 2008 and 2013 outcomes. 
  
% consults including 
diagnosis 
 
% paeds seeing 
diagnosis 
 
Duration, M (SD)# 
 
% Medication, M (SD)# 












51.3 (19.2) 48.0 (16.8) 
 
28.5 (39.2) 41.5 (39.2) 




48.7 (21.7) 46.0 (21.5) 
 
57.1 (38.4) 62.8 (38.7) 




43.6 (15.7) 43.5 (15.3) 
 
28.7 (42.7) 51.9 (42.8) 




56.4 (25.3) 46.9 (25.1) 
 
33.6 (41.6) 36.6 (41.6) 




50.9 (17.1) 48.1 (16.6) 
 
23.6 (38.4) 32.6 (38.4) 




57.1 (27.4) 46.6 (27.0) 
 
26.5 (37.6) 22.2 (37.6) 




51.0 (28.3) 51.8 (27.4) 
 
27.5 (38.6) 38.0 (38.7) 




46.6 (18.4) 42.2 (17.2) 
 
75.2 (32.0) 85.6 (31.7) 




54.4 (22.0) 45.5 (20.0) 
 
63.7 (41.7) 70.4 (41.7) 




50.5 (24.3) 46.1 (26.9) 
 
45.4 (44.0) 55.0 (44.3) 
 




49.6 (17.9) 45.9 (17.6) 
 
38.9 (32.1) 44.8 (32.2) 
             Review 
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25.5 (12.1) 26.6 (11.9) 
 
87.4 (21.0) 88.2 (21.0) 




27.0 (9.6) 28.5 (9.3) 
 
50.9 (35.9) 61.7 (36.0) 




29.6 (14.6) 29.5 (14.9) 
 
56.2 (38.5) 66.3 (38.5) 




22.6 (10.7) 21.6 (9.6) 
 
27.1 (32.1) 20.5 (30.8) 




30.7 (20.7) 31.2 (20.8) 
 
58.5 (37.7) 73.6 (37.7) 




26.9 (14.9) 32.3 (14.0) 
 
50.4 (39.6) 71.2 (39.7) 




24.3 (9.5) 26.7 (9.1) 
 
79.9 (31.2) 81.4 (31.0) 




28.7 (13.1) 29.7 (12.3) 
 
52.6 (41.3) 64.7 (41.3) 




29.6 (13.8) 30.1 (13.9) 
 
66.5 (37.7) 67.7 (37.9) 




25.1 (11.2) 25.7 (11.8) 
 
75.3 (30.7) 88.6 (30.8) 




25.5 (11.0) 27.3 (10.6) 
 
56.9 (26.0) 67.8 (25.9) 
*Bolded tests=significant (p<0.05). #Estimated mean and SD from multi-level models. †Allergy to food other than cow’s milk protein 
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Table 4: CAPS 2013 top 10 ranked new and review consultations by the 113 paediatricians who completed 2008 and 2013 audits 
  
% consults 
including diagnosis   
% paeds seeing 
diagnosis   Duration, M (SD)# 
 
% Medication, M (SD)# 
  08 13   08 13   08 13  08 13 
New 




51.8 (20.6) 49.4 (17.8) 
 
29.7 (39.0) 41.3 (39.0) 




48.9 (15.8) 47.6 (15.4) 
 
61.8 (38.1) 61.0 (38.6) 




48.7 (14.6) 44.4 (13.9) 
 
26.3 (42.5) 53.2 (42.5) 




55.5 (17.6) 47.8 (18.4) 
 
33.1 (41.7) 35.3 (41.9) 




49.6 (17.5) 50.6 (16.2) 
 
30.1 (39.7) 32.5 (39.7) 




50.5 (17.7) 46.3 (17.7) 
 
29.4 (37.9) 21.8 (37.9) 




50.3 (27.0) 52.5 (26.0) 
 
27.2 (39.6) 35.3 (39.8) 




45.2 (19.3) 44.5 (18.6) 
 
69.6 (34.9) 84.5 (34.6) 




57.2 (22.6) 45.7 (20.8) 
 
68.5 (41.9) 57.2 (41.9) 




44.9 (19.3) 48.3 (21.2) 
 
44.6 (43.5) 51.6 (43.9) 
 




49.3 (13.7) 46.9 (13.2) 
 
39.2 (32.6) 43.1 (32.8) 
             Review 
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24.8 (10.4) 26.9 (10.6) 
 
84.4 (21.4) 89.2 (21.4) 




26.9 (10.1) 29.1 (9.9) 
 
52.4 (36.0) 61.9 (36.2) 




27.8 (9.8) 28.4 (10.3) 
 
56.9 (38.8) 62.7 (39.0) 




22.0 (7.1) 20.0 (6.8) 
 
27.0 (31.9) 19.7 (31.0) 




28.8 (25.1) 31.6 (26.1) 
 
56.3 (38.1) 75.7 (38.1) 




29.0 (12.9) 30.8 (12.1) 
 
49.6 (39.4) 75.4 (39.4) 




22.9 (10.3) 27.3 (9.7) 
 
79.0 (32.3) 82.1 (32.7) 




29.0 (11.5) 30.0 (11.1) 
 
47.2 (41.6) 63.1 (41.6) 




28.8 (12.3) 29.8 (12.4) 
 
68.3 (34.2) 76.1 (34.4) 




25.6 (10.9) 25.6 (11.8) 
 
78.9 (29.7) 87.8 (29.7) 
  Total (top 10 review) 58 68  94 94  24.9 (9.5) 26.9 (9.4)  56.8 (25.7) 68.4 (25.8) 
*Bolded tests=significant (p<0.05) 
 
This article is protected by copyright. All rights reserved.
JPC_13280_f1.tif
This article is protected by copyright. All rights reserved.
